pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 22·1 min read
save

AbbVie allocates $1.4 billion for new 185-acre manufacturing campus in Durham, NC

Apr 22, 2026·read at Endpoints ↗DealNeutral

AbbVie has disclosed more details of its $100 billion pledge to the United States, setting aside $1.4 billion to build its first manufacturing campus in North Carolina.

The project will cover a 185‑acre site in Durham, with construction slated to begin in the coming months as part of the company’s expansion of domestic production capacity.

According to the announcement, AbbVie expects the campus to be completed within the timeframe of the current U.S. administration, aiming to finish while the Trump term is in office.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “AbbVie's $1.4B North Carolina manufacturing site to finish during Trump's term”

read at Endpoints ↗
95 words · retrieved Apr 26
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ABBVIE6

related stories

  • Jul 9GSK ends brain drug alliance with AlectorBioPharma Dive
  • Jul 6Apogee details path to $10.9B AbbVie deal; UK starts drug pricing pilotEndpoints
  • Jul 6Novartis to acquire ADC developer in a deal worth up to $1.5BBioPharma Dive
  • Jul 1Abivax shares surge as worries subside over immune drug’s cancer riskBioPharma Dive
  • Jun 30AbbVie and Genmab's latest win brings Epkinly closer to label expansionEndpoints